STOCK TITAN

GE HealthCare exec has 508 shares withheld for tax

GE HealthCare Technologies Inc. (GEHC) reported that Chief Commercial & Growth Officer Catherine Estrampes had shares withheld to cover taxes related to equity compensation.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reported that Chief Commercial & Growth Officer Catherine Estrampes had shares withheld to cover taxes related to equity compensation. On September 3, 2026, 508 shares of common stock were disposed of at $70.56 per share to satisfy tax withholding obligations upon the vesting of restricted stock units. After this withholding transaction, she held 23,573 shares of GE HealthCare common stock directly.

Positive

  • None.

Negative

  • None.
Insider Estrampes Catherine
Role Chief Commer. & Growth Officer
Type Security Shares Price Value
Tax Withholding Common Stock, par value $0.01 per share F1 508 $70.56 $36K
Holdings After Transaction: Common Stock, par value $0.01 per share — 23,573 shares (Direct)
Footnotes (1)
  1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Shares withheld for taxes 508 shares Withholding on September 3, 2026 to satisfy tax obligations on RSU vesting
Withholding price per share $70.56 per share Value used for the tax-withholding disposition of 508 shares
Shares held after transaction 23,573 shares Direct holdings of Catherine Estrampes following the September 3, 2026 transaction
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to satisfy tax withholding obligations in connection with the vesting"
payment of tax liability by delivering or withholding securities financial
"transaction is described as payment of tax liability by delivering or withholding securities"

FAQ

What insider transaction did GEHC report for Catherine Estrampes?

GE HealthCare reported that 508 shares of common stock held by Chief Commercial & Growth Officer Catherine Estrampes were withheld on September 3, 2026 to satisfy tax withholding obligations upon vesting of restricted stock units.

Was the GEHC Form 4 transaction a market sale or tax withholding?

The Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld to cover tax withholding obligations related to the vesting of restricted stock units.

How many GEHC shares were withheld and at what price?

The filing reports that 508 shares of GE HealthCare common stock were withheld at a price of $70.56 per share in connection with satisfying tax withholding obligations on vested restricted stock units.

How many GEHC shares does Catherine Estrampes hold after the transaction?

After the September 3, 2026 withholding transaction, Catherine Estrampes directly held 23,573 shares of GE HealthCare common stock, according to the Form 4 data.

Was the GEHC insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 data indicate that no Rule 10b5-1 trading plan is reported for this transaction; it is described as a payment of tax liability by delivering or withholding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Estrampes Catherine

(Last)(First)(Middle)
500 W. MONROE STREET

(Street)
CHICAGO ILLINOIS 60661

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commer. & Growth Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share09/03/2026F508(1)D$70.5623,573D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact09/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading